Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4 Meeting Abstract


Authors: Holmgaard, R. B.; Zamarin, D.; Munn, D. H.; Wolchok, J. D.; Allison, J. P.
Abstract Title: Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4
Meeting Title: 28th Annual Scientific Meeting of the Society for Immunotherapy of Cancer (SITC)
Journal Title: Journal for ImmunoTherapy of Cancer
Volume: 1
Issue: Suppl. 1
Meeting Dates: 2013 Nov 8-10
Meeting Location: National Harbor, MD
ISSN: 2051-1426
Publisher: Biomed Central Ltd  
Date Published: 2013-11-07
Language: English
DOI: 10.1186/2051-1426-1-S1-P77
PROVIDER: manual
PMCID: PMC3991256
Notes: Meeting Abstract: P77
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jedd D Wolchok
    905 Wolchok
  2. Dmitriy Zamarin
    202 Zamarin
  3. James P Allison
    130 Allison